PURPOSE: To evaluate the feasibility and initial functional and anatomical outcomes of transplanting a full-thickness free graft of choroid and retinal pigment epithelium (RPE), along with neurosensory retina in advanced fibrosis and atrophy associated with end-stage exudative age-related macular degeneration with and without a concurrent refractory macular hole. METHODS: During vitrectomy, an RPE-choroidal and neurosensory retinal free graft was harvested in nine eyes of nine patients. The RPE-choroidal and neurosensory retinal free graft was either placed subretinally (n = 5), intraretinally to cover the foveal area inside an iatrogenically induced macular hole over the RPE-choroidal graft (n = 3) or preretinally (n = 1) without a retinotomy wherein both free grafts were placed over the concurrent macular hole. Silicone oil endotamponade was used in all cases. RESULTS: Mean follow-up was 7 ± 5.5 months (range 3-19). The mean preoperative visual acuity was ∼count fingers (logarithm of the minimum angle of resolution = 2.11, range 2-3), which improved to ∼20/800 (logarithm of the minimum angle of resolution 1.62 ± 0.48, range 0.7-2, P = 0.04). Vision was stable in 5 eyes (55.6%) and improved in 4 eyes (44.4%). Reading ability improved in 5 eyes (55.6%). Postoperative complications were graft atrophy (n = 1), epiretinal membrane (n = 1), and dislocation of neurosensory retina-choroid-RPE free graft (n = 1). CONCLUSION: Combined autologous RPE-choroid and neurosensory retinal free graft is a potential surgical alternative in eyes with end-stage exudative age-related macular degeneration, including concurrent refractory macular hole.
PURPOSE: To evaluate the feasibility and initial functional and anatomical outcomes of transplanting a full-thickness free graft of choroid and retinal pigment epithelium (RPE), along with neurosensory retina in advanced fibrosis and atrophy associated with end-stage exudative age-related macular degeneration with and without a concurrent refractory macular hole. METHODS: During vitrectomy, an RPE-choroidal and neurosensory retinal free graft was harvested in nine eyes of nine patients. The RPE-choroidal and neurosensory retinal free graft was either placed subretinally (n = 5), intraretinally to cover the foveal area inside an iatrogenically induced macular hole over the RPE-choroidal graft (n = 3) or preretinally (n = 1) without a retinotomy wherein both free grafts were placed over the concurrent macular hole. Silicone oil endotamponade was used in all cases. RESULTS: Mean follow-up was 7 ± 5.5 months (range 3-19). The mean preoperative visual acuity was ∼count fingers (logarithm of the minimum angle of resolution = 2.11, range 2-3), which improved to ∼20/800 (logarithm of the minimum angle of resolution 1.62 ± 0.48, range 0.7-2, P = 0.04). Vision was stable in 5 eyes (55.6%) and improved in 4 eyes (44.4%). Reading ability improved in 5 eyes (55.6%). Postoperative complications were graft atrophy (n = 1), epiretinal membrane (n = 1), and dislocation of neurosensory retina-choroid-RPE free graft (n = 1). CONCLUSION: Combined autologous RPE-choroid and neurosensory retinal free graft is a potential surgical alternative in eyes with end-stage exudative age-related macular degeneration, including concurrent refractory macular hole.
Authors: Kristel J M Maaijwee; Jan C van Meurs; Bernd Kirchhof; Cornelia M Mooij; Jurgen H Fischer; Jerzy Mackiewicz; Karin Kobuch; Antonia M Joussen Journal: Br J Ophthalmol Date: 2006-09-20 Impact factor: 4.638
Authors: Antonia M Joussen; Sandra Joeres; Nader Fawzy; Florian M A Heussen; Helene Llacer; Jan C van Meurs; Bernd Kirchhof Journal: Ophthalmology Date: 2007-03 Impact factor: 12.079
Authors: Sabine Aisenbrey; Bart A Lafaut; Peter Szurman; Salvatore Grisanti; Christoph Lüke; Ralf Krott; Gabriele Thumann; Julia Fricke; Antje Neugebauer; Ralf-Dieter Hilgers; Peter Esser; Peter Walter; Karl Ulrich Bartz-Schmidt Journal: Arch Ophthalmol Date: 2002-04
Authors: Kristel Maaijwee; Heinrich Heimann; Tom Missotten; Paul Mulder; Antonia Joussen; Jan van Meurs Journal: Graefes Arch Clin Exp Ophthalmol Date: 2007-06-12 Impact factor: 3.117
Authors: F M A Heussen; N F Fawzy; S Joeres; A Lux; K Maaijwee; J Cv Meurs; B Kirchhof; A M Joussen Journal: Eye (Lond) Date: 2007-07-20 Impact factor: 3.775
Authors: J C van Meurs; E ter Averst; L J Hofland; P M van Hagen; C M Mooy; G S Baarsma; R W Kuijpers; T Boks; P Stalmans Journal: Br J Ophthalmol Date: 2004-01 Impact factor: 4.638
Authors: Paulo E Stanga; Andres Kychenthal; Frederick W Fitzke; Anthony S Halfyard; Roger Chan; Alan C Bird; George W Aylward Journal: Ophthalmology Date: 2002-08 Impact factor: 12.079